Literature DB >> 35396262

High-Resolution Mass Spectrometry for the Measurement of PTH and PTH Fragments: Insights into PTH Physiology and Bioactivity.

Candice Z Ulmer1, Kittrawee Kritmetapak2, Ravinder J Singh3,4, Hubert W Vesper1, Rajiv Kumar5,6.   

Abstract

Full-length parathyroid hormone (PTH 1-84) is crucial for the regulation of calcium and phosphate homeostasis and bone remodeling. PTH 1-84 is metabolized into various PTH fragments, which are measured with varying levels of efficiency by PTH immunoassays. These PTH fragments, which increase in serum as CKD progresses, could potentially modulate the effects of PTH 1-84 and contribute to CKD-associated bone disorders. To obtain a true biologic representation of total PTH bioactivity, it is necessary to measure not only PTH 1-84 but also PTH fragments that are present in circulation. Traditional second-generation PTH immunoassays collectively measure PTH 1-84, PTH fragments, and post-translationally modified PTH 1-84, making it difficult to accurately predict the character of underlying renal osteodystrophy. This review highlights current advances in methods available for PTH measurement and the clinical relevance of PTH fragments in CKD. We emphasize the usefulness of mass spectrometry as a potential reference method for PTH measurement.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  mass spectrometry; mineral metabolism; parathyroid hormone

Mesh:

Substances:

Year:  2022        PMID: 35396262      PMCID: PMC9342634          DOI: 10.1681/ASN.2022010036

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   14.978


  77 in total

1.  The renal handling of parathyroid hormone. Role of peritubular uptake and glomerular filtration.

Authors:  K J Martin; K A Hruska; J Lewis; C Anderson; E Slatopolsky
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

2.  Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease.

Authors:  Stan R Ursem; Annemieke C Heijboer; Patrick C D'Haese; Geert J Behets; Etienne Cavalier; Marc G Vervloet; Pieter Evenepoel
Journal:  Kidney Int       Date:  2021-01-08       Impact factor: 10.612

3.  The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma.

Authors:  Etienne Cavalier; Adrian F Daly; Daniela Betea; Pamela Nicoleta Pruteanu-Apetrii; Pierre Delanaye; Phil Stubbs; Arthur R Bradwell; Jean-Paul Chapelle; Albert Beckers
Journal:  J Clin Endocrinol Metab       Date:  2010-06-02       Impact factor: 5.958

4.  Effects of PTH, ADH, and cyclic AMP on distal tubular Ca and Na reabsorption.

Authors:  L S Costanzo; E E Windhager
Journal:  Am J Physiol       Date:  1980-11

5.  The (1-14) fragment of parathyroid hormone (PTH) activates intact and amino-terminally truncated PTH-1 receptors.

Authors:  M D Luck; P H Carter; T J Gardella
Journal:  Mol Endocrinol       Date:  1999-05

Review 6.  Parathyroid hormone metabolism and signaling in health and chronic kidney disease.

Authors:  Pieter Evenepoel; Jordi Bover; Pablo Ureña Torres
Journal:  Kidney Int       Date:  2016-09-18       Impact factor: 10.612

7.  Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure.

Authors:  M Chris Langub; Marie-Claude Monier-Faugere; Guodong Wang; John P Williams; Nicholas J Koszewski; Hartmut H Malluche
Journal:  Endocrinology       Date:  2003-04       Impact factor: 4.736

8.  Peripheral metabolism of intact parathyroid hormone. Role of liver and kidney and the effect of chronic renal failure.

Authors:  K A Hruska; A Korkor; K Martin; E Slatopolsky
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

9.  Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)2D and normal FGF7 concentrations characterize patients with CKD.

Authors:  Kittrawee Kritmetapak; Louis Losbanos; Taylor E Berent; Susan L Ashrafzadeh-Kian; Alicia Algeciras-Schimnich; Jolaine M Hines; Ravinder J Singh; Rajiv Kumar
Journal:  BMC Nephrol       Date:  2021-03-30       Impact factor: 2.388

10.  Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure.

Authors:  Kittrawee Kritmetapak; Louis A Losbanos; Jolaine M Hines; Katherine L O'Grady; Candice Z Ulmer; Hubert W Vesper; Felicity T Enders; Ravinder J Singh; Rajiv Kumar
Journal:  Clin Chem       Date:  2021-06-01       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.